Table of contents
Volume 88, Issue 5
Published online 4 March 2003 (645-802)
Clinical
Peptide receptor radiotherapy: a new option for the management of aggressive fibromatosis on behalf of the Italian Sarcoma Group FREE
T De Pas, L Bodei, G Pelosi, F de Braud, G Villa, R Capanna and G Paganelli
Br J Cancer 88: 645-647; doi:10.1038/sj.bjc.6600823
EORTC Early Clinical Studies Group early phase II trial of S-1 in patients with advanced or metastatic colorectal cancer FREE
J Van den Brande, P Schöffski, J H M Schellens, A D Roth, F Duffaud, K Weigang-Köhler, F Reinke, J Wanders, R F de Boer, J B Vermorken and P Fumoleau
Br J Cancer 88: 648-653; doi:10.1038/sj.bjc.6600781
Carcinosarcoma of the ovary FREE
M A Harris, L M Delap, P S Sengupta, P M Wilkinson, R S Welch, R Swindell, J H Shanks, G Wilson, R J Slade, K Reynolds and G C Jayson
Br J Cancer 88: 654-657; doi:10.1038/sj.bjc.6600770
Association of perceived physician communication style with patient satisfaction, distress, cancer-related self-efficacy, and perceived control over the disease FREE
R Zachariae, C G Pedersen, A B Jensen, E Ehrnrooth, P B Rossen and H von der Maase
Br J Cancer 88: 658-665; doi:10.1038/sj.bjc.6600798
Lack of communication between healthcare professionals and women with ovarian cancer about sexual issues FREE
M L Stead, J M Brown, L Fallowfield and P Selby
Br J Cancer 88: 666-671; doi:10.1038/sj.bjc.6600799
Epidemiology
Aspirin use and cancers of the upper aerodigestive tract FREE
C Bosetti, R Talamini, S Franceschi, E Negri, W Garavello and C La Vecchia
Br J Cancer 88: 672-674; doi:10.1038/sj.bjc.6600820
Genetic polymorphisms of cytochrome P450 19 and 1B1, alcohol use, and breast cancer risk in Korean women FREE
K-M Lee, J Abel, Y Ko, V Harth, W-Y Park, J-S Seo, K-Y Yoo, J-Y Choi, A Shin, S-H Ahn, D-Y Noh, A Hirvonen and D Kang
Br J Cancer 88: 675-678; doi:10.1038/sj.bjc.6600761
Physical activity, body weight, and pancreatic cancer mortality FREE
I-M Lee, H D Sesso, Y Oguma and R S Paffenbarger Jr
Br J Cancer 88: 679-683; doi:10.1038/sj.bjc.6600782
A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin FREE
S Friis, H T Sørensen, J K McLaughlin, S P Johnsen, W J Blot and J H Olsen
Br J Cancer 88: 684-688; doi:10.1038/sj.bjc.6600760
Vegetables and fruit intake and cancer mortality in the Hiroshima/Nagasaki Life Span Study FREE
C Sauvaget, J Nagano, M Hayashi, E Spencer, Y Shimizu and N Allen
Br J Cancer 88: 689-694; doi:10.1038/sj.bjc.6600775
Childhood leukaemia and non-Hodgkin's lymphoma in relation to proximity to railways FREE
H O Dickinson, D M Hammal, T J B Dummer, L Parker and J F Bithell
Br J Cancer 88: 695-698; doi:10.1038/sj.bjc.6600762
Molecular and Cellular Pathology
KOC is a novel molecular indicator of malignancy FREE
F Mueller, M Bommer, U Lacher, C Ruhland, V Stagge, G Adler, T M Gress and T Seufferlein
Br J Cancer 88: 699-701; doi:10.1038/sj.bjc.6600790
Ultrasonographically-guided fine-needle aspiration of axillary lymph nodes: role in breast cancer management FREE
A Sapino, P Cassoni, E Zanon, F Fraire, S Croce, C Coluccia, M Donadio and G Bussolati
Br J Cancer 88: 702-706; doi:10.1038/sj.bjc.6600744
The influence of tamoxifen treatment on the oestrogen receptor in metachronous contralateral breast cancer FREE
R Kaas, J L Peterse, A A M Hart, A C Voogd, E J T Rutgers and F E van Leeuwen
Br J Cancer 88: 707-710; doi:10.1038/sj.bjc.6600746
Molecular analysis of local relapse in high-risk breast cancer patients: can radiotherapy fractionation and time factors make a difference? FREE
M I Koukourakis, A Giatromanolaki, G Galazios and E Sivridis for the Tumour and Angiogenesis Research Group
Br J Cancer 88: 711-717; doi:10.1038/sj.bjc.6600755
Inflammatory breast cancer shows angiogenesis with high endothelial proliferation rate and strong E-cadherin expression FREE
C G Colpaert, P B Vermeulen, I Benoy, A Soubry, F Van Roy, P van Beest, G Goovaerts, L Y Dirix, P Van Dam, S B Fox, A L Harris and E A Van Marck
Br J Cancer 88: 718-725; doi:10.1038/sj.bjc.6600807
Prognostic significance of dysadherin expression in advanced colorectal carcinoma FREE
S Aoki, T Shimamura, T Shibata, Y Nakanishi, Y Moriya, Y Sato, M Kitajima, M Sakamoto and S Hirohashi
Br J Cancer 88: 726-732; doi:10.1038/sj.bjc.6600778
Focal overexpression of insulin-like growth factor 2 by hepatocytes and cholangiocytes in viral liver cirrhosis FREE
N Sedlaczek, A Hasilik, P Neuhaus, D Schuppan and H Herbst
Br J Cancer 88: 733-739; doi:10.1038/sj.bjc.6600777
Impaired 
Np63 expression associates with reduced 
-catenin and aggressive phenotypes of urothelial neoplasms FREE
F Koga, S Kawakami, J Kumagai, T Takizawa, N Ando, G Arai, Y Kageyama and K Kihara
Br J Cancer 88: 740-747; doi:10.1038/sj.bjc.6600764
Opposing effects of butyrate and bile acids on apoptosis of human colon adenoma cells: differential activation of PKC and MAP kinases FREE
L McMillan, S K Butcher, J Pongracz and J M Lord
Br J Cancer 88: 748-753; doi:10.1038/sj.bjc.6600793
Experimental Therapeutics
p53 protein regulates the effects of amifostine on apoptosis, cell cycle progression, and cytoprotection FREE
E J Lee, M Gerhold, M W Palmer and R D Christen
Br J Cancer 88: 754-759; doi:10.1038/sj.bjc.6600779
Ischaemia-reperfusion injury in photodynamic therapy-treated mouse tumours FREE
M Korbelik, J Sun and H Zeng
Br J Cancer 88: 760-766; doi:10.1038/sj.bjc.6600792
A proliferation-dependent bystander effect in primary porcine and human urothelial explants in response to targeted irradiation FREE
O V Belyakov, M Folkard, C Mothersill, K M Prise and B D Michael
Br J Cancer 88: 767-774; doi:10.1038/sj.bjc.6600804
Cell proliferation is related to in vitro drug resistance in childhood acute leukaemia FREE
P Kaaijk, G J L Kaspers, E R van Wering, G J Broekema, A H Loonen, K Hählen, K Schmiegelow, G E Janka-Schaub, G Henze, U Creutzig and A J P Veerman
Br J Cancer 88: 775-781; doi:10.1038/sj.bjc.6600787
Penetration of capecitabine and its metabolites into malignant and healthy tissues of patients with advanced breast cancer FREE
R M Mader, C Schrolnberger, B Rizovski, M Brunner, C Wenzel, G Locker, H G Eichler, M Mueller and G G Steger
Br J Cancer 88: 782-787; doi:10.1038/sj.bjc.6600809
Endothelin-receptor antagonists are proapoptotic and antiproliferative in human colon cancer cells FREE
L Peduto Eberl, R Bovey and L Juillerat-Jeanneret
Br J Cancer 88: 788-795; doi:10.1038/sj.bjc.6600810
Induction of neuropilin-1 and vascular endothelial growth factor by epidermal growth factor in human gastric cancer cells FREE
M Akagi, M Kawaguchi, W Liu, M F McCarty, A Takeda, F Fan, O Stoeltzing, A A Parikh, Y D Jung, C D Bucana, P F Mansfield, D J Hicklin and L M Ellis
Br J Cancer 88: 796-802; doi:10.1038/sj.bjc.6600811
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
